A Phase 4 interventional study of progesterone and Progesterone in IVF - Luteal Phase Support After Embryo Transfer, sponsored by Nordica Fertility Clinic. Status unknown at 17 sites in 2 countries. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2008-07-02.
Sponsored by Nordica Fertility Clinic · Phase 4, Interventional, and Treatment
To compare the effect of Crinone 8% administered once daily versus other vaginal progesterone in terms of ongoing pregnancy rate 5 weeks after embryo transfer as well as patient convenience.
This is the only study on the registry with Nordica Fertility Clinic as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Crinone vaginal gel 8% 90 mg once daily
Drug: progesterone
Progesterone mic 400 mg three times daily
Drug: Progesterone
90 mg, vaginal, once daily
Also known as: crinone 8%
200 mg, vaginal, three times daily used in Denmark, 400 mg, vaginal, three times daily used in Sweden
Also known as: Progestan in Denmark, Progesterone mic in Sweden
Equivalence in ongoing pregnancy per embryo transfer between the two groups
Time frame: week 5 after embryo tranfer
Convenience for the patient
Time frame: the treatment period (from the day of embryo transfer and 19 days ahead)
This study is status unknown, as verified in Jul 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.